{"id":195,"date":"2015-04-16T18:00:12","date_gmt":"2015-04-16T16:00:12","guid":{"rendered":"http:\/\/imuna.sk\/?p=195"},"modified":"2020-08-12T11:30:02","modified_gmt":"2020-08-12T09:30:02","slug":"immodin","status":"publish","type":"post","link":"https:\/\/www.imuna.sk\/en\/produkty\/imunopreparaty\/immodin\/","title":{"rendered":"IMMODIN\u00ae"},"content":{"rendered":"<p><div class=\"odborna-verejnost\"><\/p>\n<p><em>Pharmacotherapeutic group:<\/em><br \/>\n<strong>Immunopreparations (ATC code: L03AX)<\/strong><\/p>\n<h3>Characteristics:<\/h3>\n<p>IMMODIN\u00ae (lyophylised human leucocyte-derived dialysate) is a mixture of biologically active immunomodulating agents. Active substances in IMMODIN\u00ae affect proliferation and differentiation of different types of cells, i.e. maturation into functional stages. The drug is indicated in cellular immune disorders that have been demonstrated in children from 6 months of age, adolescents and adults.<\/p>\n<p>For detailed information click <a href=\"http:\/\/imuna.sk\/wp-content\/uploads\/2015\/04\/IMMODIN-Abridged-Drug-Information.pdf\" target=\"_blank\">here<\/a>.<\/p>\n<\/div>\n<div class=\"laicka-verejnost\">\n<p><em>Pharmacotherapeutic group:<\/em><br \/>\n<strong>Immunopreparations<\/strong><\/p>\n<h3>Characteristics:<\/h3>\n<p>IMMODIN\u00ae contains biologically active substances liable to normalise specific cell-mediated immunity of the recipient. IMMODIN\u00ae is indicated in cellular immune disorders that have been demonstrated in children from 6 months of age, adolescents and adults. <\/p>\n<p>For detailed information click <a href=\"http:\/\/imuna.sk\/wp-content\/uploads\/2015\/04\/IMMODIN-Abridged-Drug-Information.pdf\" target=\"_blank\">here<\/a>.<\/p>\n<p><\/div><\/p>","protected":false},"excerpt":{"rendered":"<p>Pharmacotherapeutic group: Immunopreparations (ATC code: L03AX) Characteristics: IMMODIN\u00ae (lyophylised human leucocyte-derived dialysate) is a mixture of biologically active immunomodulating agents. Active substances in IMMODIN\u00ae affect proliferation and differentiation of different types of cells, i.e. maturation into functional stages. The drug is indicated in cellular immune disorders that have been demonstrated in children from 6 months [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":208,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[7],"tags":[],"_links":{"self":[{"href":"https:\/\/www.imuna.sk\/en\/wp-json\/wp\/v2\/posts\/195"}],"collection":[{"href":"https:\/\/www.imuna.sk\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.imuna.sk\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.imuna.sk\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.imuna.sk\/en\/wp-json\/wp\/v2\/comments?post=195"}],"version-history":[{"count":3,"href":"https:\/\/www.imuna.sk\/en\/wp-json\/wp\/v2\/posts\/195\/revisions"}],"predecessor-version":[{"id":1473,"href":"https:\/\/www.imuna.sk\/en\/wp-json\/wp\/v2\/posts\/195\/revisions\/1473"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.imuna.sk\/en\/wp-json\/wp\/v2\/media\/208"}],"wp:attachment":[{"href":"https:\/\/www.imuna.sk\/en\/wp-json\/wp\/v2\/media?parent=195"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.imuna.sk\/en\/wp-json\/wp\/v2\/categories?post=195"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.imuna.sk\/en\/wp-json\/wp\/v2\/tags?post=195"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}